Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07YVK
|
|||
Former ID |
DCL001006
|
|||
Drug Name |
Sumanirole
|
|||
Synonyms |
PNU 95666; U 95666E; PNU-95666; [2-[(1R)-1-(methylamino)ethyl]phenyl]methanol; Benzenemethanol, alpha-((1R)-1-(methylamino)ethyl)-, (alphaS)-rel-, 2-naphthalenesulfonate (salt); 2-Naphthalenesulfonic acid, compd with (R*,S*)-alpha-(1-(methylamino)ethyl)benzenemethanol (1:1); 2-Naphthalenesulfonic acid, compd with rel-(alphaS)-alpha-((1R)-1-(methylamino)ethyl)benzenemethanol (1:1)
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Parkinson disease [ICD-11: 8A00.0; ICD-9: 332] | Phase 3 | [1], [2] | |
Company |
Pfizer
|
|||
Structure |
Download2D MOL |
|||
Formula |
C11H13N3O
|
|||
Canonical SMILES |
CNC1CC2=C3C(=CC=C2)NC(=O)N3C1
|
|||
InChI |
1S/C11H13N3O/c1-12-8-5-7-3-2-4-9-10(7)14(6-8)11(15)13-9/h2-4,8,12H,5-6H2,1H3,(H,13,15)/t8-/m1/s1
|
|||
InChIKey |
RKZSNTNMEFVBDT-MRVPVSSYSA-N
|
|||
CAS Number |
CAS 179386-43-7
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
14797551, 15195581, 24122573, 44854443, 75621928, 103357480, 103952699, 129144523, 134224983, 134340821, 135261297, 141993172, 160835859, 163097331, 163399818, 163773618, 163846019, 164765184, 172914815, 174006884, 178100776, 198967559, 204431143, 210276636, 223556709, 225376294, 226518850, 242589478
|
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3949). | |||
REF 2 | Drugs used to treat Parkinson's disease, present status and future directions. CNS Neurol Disord Drug Targets. 2008 Oct;7(4):321-42. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.